About
Microbiome therapeutics platform
Areas of Focus
Categories
Drug Delivery & FormulationMicrobiome
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
6
As Collaborator
4
Total Enrollment
321
By Phase
PHASE2: 2NA: 2PHASE1: 4PHASE2/PHASE3: 1EARLY_PHASE1: 1
By Status
COMPLETED: 5UNKNOWN: 2ACTIVE_NOT_RECRUITING: 2WITHDRAWN: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05743777Collaborator
PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma
PHASE2Withdrawn
Started: May 12, 2023 · Completed: May 12, 2023
NCT06381193Collaborator
Study for the Management of Chronic and Functional Constipation Through the Intake of Probiotics and Prebiotics
NACompleted
80 participants
Started: Mar 3, 2023 · Completed: Jul 10, 2023
NCT04602715Lead Sponsor
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression
PHASE2Unknown
60 participants
Started: Apr 1, 2021 · Completed: Jun 30, 2021
NCT04507971Lead Sponsor
Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia
PHASE1Unknown
20 participants
Started: Jun 22, 2020 · Completed: Dec 31, 2021
NCT03838601Collaborator
Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2
NAActive, not recruiting
30 participants
Started: Jul 2, 2019 · Completed: Mar 31, 2026
Locations (1)
Headquarters
Guelph, ON, Canada
Map
Loading map...